Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Elizabeth A. Shaughnessy"'
Autor:
Jaime D. Lewis, Anees B. Chagpar, Elizabeth A. Shaughnessy, Jacob Nurko, Kelly McMasters, Michael J. Edwards
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 3, Pp 25-35 (2014)
Fareston (toremifene) and tamoxifen, both selective estrogen receptor modulators, are therapeutically equivalent treatments for metastatic breast cancer. We hypothesized that toremifene as compared with tamoxifen given as adjuvant therapy for early s
Externí odkaz:
https://doaj.org/article/3e9e5544eb6f4184967c18df01ed5d88
Autor:
Camila R. Guetter, Maria S. Altieri, Marion C.W. Henry, Elizabeth A. Shaughnessy, Sadia Tasnim, Yangyang R. Yu, Sanda A. Tan
Publikováno v:
The American Journal of Surgery. 224:1334-1336
Publikováno v:
Precision Medicine in Neurodegenerative Disorders, Part I ISBN: 9780323855389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::202c05da75dee9d4f28f5c58facca004
https://doi.org/10.1016/b978-0-323-85538-9.00003-1
https://doi.org/10.1016/b978-0-323-85538-9.00003-1
Publikováno v:
Am J Physiol Cell Physiol
Breast cancer is the quintessential example of how molecular characterization of tumor biology guides therapeutic decisions. From the discovery of the estrogen receptor to current clinical molecular profiles to evolving single-cell analytics, the cha
Autor:
Jaime D. Lewis, Mackenzie C. Morris, Chantal Reyna, Michael E. Johnston, Dennis J. Hanseman, Elizabeth A. Shaughnessy, Tiffany C. Lee
Publikováno v:
Breast Cancer Research and Treatment. 189:155-166
Previous studies have suggested axillary lymph node dissection (ALND) can be omitted in early breast cancer patients undergoing mastectomy with positive lymph nodes (LNs). We assessed the national utilization of ALND and overall survival (OS) for lar
National Trend of Axillary Management in Clinical T3/T4 N0 Patients Having Breast Conserving Therapy
Autor:
Mackenzie C. Morris, Elizabeth A. Shaughnessy, Jaime D. Lewis, Tiffany C. Lee, Michael E. Johnston, Dennis J. Hanseman, Chantal Reyna
Publikováno v:
Journal of Surgical Research. 255:361-370
The ACOSOG Z0011 trial has essentially eliminated axillary lymph node dissection (ALND) in breast conserving therapy (BCT) patients with clinical T1/T2 and 1-2 positive sentinel lymph nodes (SLNs). Currently, ALND is recommended for positive SLNs unl
Autor:
Cheryl K, Zogg, Lyndsay A, Kandi, Hannah S, Thomas, Mary A, Siki, Ashley Y, Choi, Camila R, Guetter, Charlotte B, Smith, Erica, Maduakolam, Shreya, Kondle, Sharon L, Stein, Elizabeth A, Shaughnessy, Nita, Ahuja
Publikováno v:
JAMA Surgery. 158:e226431
ImportanceA growing body of literature has been developed with the goal of attempting to understand the experiences of female surgeons. While it has helped to address inequities and promote important programmatic improvements, work remains to be done
Autor:
Jaime D. Lewis, Elizabeth A. Shaughnessy, Dennis J. Hanseman, Benjamin H. Hinrichs, Leah K. Winer, Sisi Lu, Yuan Huang, Chantal Reyna
Publikováno v:
The American Journal of Surgery. 218:730-736
Background We determined the sampling error rate of flat epithelial atypia (FEA) and evaluated current guidelines recommending excisional biopsy. Methods A retrospective review of consecutive excisional biopsies after image-guided core-needle biopsy
Autor:
Chantal, Reyna, Michael E, Johnston, Mackenzie C, Morris, Tiffany C, Lee, Dennis, Hanseman, Elizabeth A, Shaughnessy, Jaime D, Lewis
Publikováno v:
Breast cancer research and treatment. 189(1)
Previous studies have suggested axillary lymph node dissection (ALND) can be omitted in early breast cancer patients undergoing mastectomy with positive lymph nodes (LNs). We assessed the national utilization of ALND and overall survival (OS) for lar
Autor:
Elizabeth A. Shaughnessy, Michelle Barrord, Teresa Meier, Dennis J. Hanseman, Chantal Reyna, Michela M. Carter, Jaime D. Lewis
Publikováno v:
The Journal of surgical research. 268
Sentinel Lymph Node Biopsy (SLNB) is standard of care for women with clinically N0 breast cancer. However, there are no randomized controlled studies in men determining optimal surgical axillary management.Using the National Cancer Database, males di